Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women

被引:46
作者
Folsom, AR
Golden, SH
Boland, LL
Szklo, M
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Epidemiol, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
关键词
androgens; C-reactive protein; estrone; fibrinogen; white blood cells;
D O I
10.1007/s10654-005-3657-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
Oral exogenous estrogen raises C-reactive protein (CRP) concentrations, but the impact of endogenous hormones is unknown. We examined the cross-sectional relation of several serum hormones with CRP, fibrinogen, and white blood cell count - three inflammatory markers linked prospectively to coronary artery disease. Serum hormones were measured on a sample (n=317) of postmenopausal female participants, with or without carotid intima-media thickening, in the Atherosclerosis Risk in Communities (ARIC) Study. Fibrinogen and white blood cell count were available on all and CRP in a subset (n=57). Adjusted for age, race, and case-control status, mean CRP was 2-fold greater in the highest vs. lowest quartiles of estrone and androstenedione, and CRP was 2-fold less across quartiles of sex hormone binding globulin. These associations were not all statistically significant with this sample size. Fibrinogen and white blood cell count also were associated positively with estrone, androstenedione, and testosterone (and fibrinogen also with dehydroepiandrosterone sulfate). Adjustment for other risk factors and especially body mass index, a known determinant of endogenous hormone levels, attenuated most associations. In conclusion, several endogenous sex hormones may influence basal levels of inflammatory markers. Obesity appears to play a modulating role.
引用
收藏
页码:1015 / 1022
页数:8
相关论文
共 43 条
[1]
Effects of hormone replacement therapy on hemostatic cardiovascular risk factors [J].
Andersen, LF ;
Gram, J ;
Skouby, SO ;
Jespersen, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (02) :283-289
[2]
Effect of oral postmenopausal hormone replacement on progression of atherosclerosis -: A randomized, controlled trial [J].
Angerer, P ;
Störk, S ;
Kothny, W ;
Schmitt, P ;
von Schacky, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (02) :262-268
[3]
Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women [J].
Brooks-Asplund, EM ;
Tupper, CE ;
Daun, JM ;
Kenney, WL ;
Cannon, JG .
CYTOKINE, 2002, 19 (04) :193-200
[4]
RELIABILITY AND INTERRELATIONS AMONG SERUM SEX-HORMONES IN POSTMENOPAUSAL WOMEN [J].
CAULEY, JA ;
GUTAI, JP ;
KULLER, LH ;
POWELL, JG .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 133 (01) :50-57
[5]
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[6]
Effect of postmenopausal hormones on inflammation-sensitive proteins - The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study [J].
Cushman, M ;
Legault, C ;
Barrett-Connor, E ;
Stefanick, ML ;
Kessler, C ;
Judd, HL ;
Sakkinen, PA ;
Tracy, RP .
CIRCULATION, 1999, 100 (07) :717-722
[7]
Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation [J].
Cushman, M .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (01) :7F-10F
[8]
Tamoxifen and cardiac risk factors in healthy women - Suggestion of an anti-inflammatory effect [J].
Cushman, M ;
Costantino, JP ;
Tracy, RP ;
Song, K ;
Buckley, L ;
Roberts, JD ;
Krag, DN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (02) :255-261
[9]
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].
Danesh, J ;
Whincup, P ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Appleby, P ;
Gallimore, JR ;
Pepys, MB .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204
[10]
Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women - A 2-year, placebo-controlled study [J].
de Valk-de Roo, GW ;
Stehouwer, CDA ;
Meijer, P ;
Mijatovic, V ;
Kluft, C ;
Kenemans, P ;
Cohen, F ;
Watts, S ;
Netelenbos, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) :2993-3000